Manufacturing and Supply Chain Capabilities Manufact_Img American Regent’s manufacturing operation is made up of three facilities, situated in New York and Ohio, totaling over 100,000 square feet of manufacturing and packaging space. The operation includes traditional high-speed, high-output fill-finish facilities as well as a state-of-the-art facility that is capable of manufacturing cytotoxic compounds in both liquid and lyophilized formats. American Regent is capable of manufacturing a broad range of batch sizes with fill volumes from 1 mL to 100 mL in vials sizes from 2 mL to 100 mL, is able to package products in glass vials and ampules, and can manufacture up to 70 million units per year.




© 2017, American Regent, Inc., A Luitpold Pharmaceuticals, Inc. Company
PP-AS-US-0014     4/2017